CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation

Overview of attention for article published in Frontiers in immunology, December 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 38,564 followers.

RT @PieriniLab: Happy to share our latest review about Treg therapies in HCT. Some ideas to expand the field! #Treg #BMT #tolerance https:/…

Happy to share our latest review about Treg therapies in HCT. Some ideas to expand the field! #Treg #BMT #tolerance https://t.co/vijQ372wn6

RT @FrontImmunol: New Research: CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation: Since their dis…

RT @FrontImmunol: New Research: CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation: Since their dis…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.